Galapagos NV (FRA:GXE)
€ 25.82 0.14 (0.55%) Market Cap: 1.73 Bil Enterprise Value: -1.60 Bil PE Ratio: 8.38 PB Ratio: 0.60 GF Score: 54/100

Galapagos NV at JPMorgan Healthcare Conference Transcript

Jan 13, 2022 / 01:15PM GMT
Release Date Price: €45.79 (-0.46%)
Laerke L. Engkilde
JPMorgan Chase & Co, Research Division - Analyst

Welcome, everyone, to day 4 and the final day of the JPMorgan Healthcare Conference. I'm Laerke Engkilde, European pharma and biotech analyst. And it is my great pleasure to introduce from Galapagos, the CEO, Onno Van De Stolpe.

(Operator Instructions) And I will then ask your questions for you once we get to the Q&A portion of this session. With that, over to Onno. Welcome to the conference.

Onno Van De Stolpe
Galapagos NV - Co-Founder, Chairman of the Management Board, MD & CEO

Thank you, Laerke. Thank you for giving the opportunity to present, and thank you all for joining this presentation by Galapagos, which is somewhat of a milestone because it will be the last presentation where I will be representing Galapagos after 23 years. I will be retiring this year. So it's rather unfortunate that it has to be virtual, but that is the reality of today.

Let's go to the disclaimer. Please take a moment to read that in your time, we don't have to go -- time to go

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot